NeuroPace Inc - Common Stock, .001 par value per share (NPCE)

Historical Holders from Q2 2021 to Q1 2025

Symbol
NPCE on Nasdaq
CUSIP
641288105
Type / Class
Equity / Common Stock, .001 par value per share
Shares outstanding
30.3M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
20.9M
Holdings value
$234M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
61
Number of buys
33
Number of sells
-14
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NeuroPace Inc - Common Stock, .001 par value per share (NPCE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KCK LTD. 17.7% $57.8M 5.27M KCK LTD. Dec 31, 2024
MORGAN STANLEY 8.3% $27.3M 2.49M Morgan Stanley Dec 31, 2024
Kent Lake PR LLC 4.9% -2% $16.3M $110K 1.48M +0.68% Kent Lake PR LLC Dec 31, 2024

Institutional Holders of NeuroPace Inc - Common Stock, .001 par value per share (NPCE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 17.6K $217K +$32.7K $12.29 4
2024 Q4 20.9M $234M +$8.99M $11.19 61
2024 Q3 14.8M $103M +$1.48M $6.97 48
2024 Q2 14.4M $109M +$4.46M $7.56 52
2024 Q1 13.4M $176M +$8.75M $13.20 54
2023 Q4 12.7M $131M +$1.82M $10.31 41
2023 Q3 18.1M $176M +$5.56M $9.73 24
2023 Q2 17.5M $78.6M -$756K $4.49 20
2023 Q1 17.7M $82M +$1.75M $4.64 23
2022 Q4 17.4M $25.9M -$2.68M $1.49 22
2022 Q3 18.2M $68.1M -$1.03M $3.75 26
2022 Q2 16.4M $81.3M -$3.17M $4.95 24
2022 Q1 17.2M $141M -$6.43M $8.21 36
2021 Q4 17.7M $179M +$633K $10.08 39
2021 Q3 11.2M $177M +$509K $15.85 39
2021 Q2 10.9M $259M +$259M $23.79 44